| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA-directed DNA polymerase activity | 2.63e-09 | 14 | 200 | 6 | GO:0003964 | |
| GeneOntologyMolecularFunction | RNA-DNA hybrid ribonuclease activity | 4.22e-08 | 11 | 200 | 5 | GO:0004523 | |
| GeneOntologyMolecularFunction | RNA stem-loop binding | 1.71e-06 | 21 | 200 | 5 | GO:0035613 | |
| GeneOntologyMolecularFunction | DNA polymerase activity | 1.98e-06 | 38 | 200 | 6 | GO:0034061 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity, producing 5'-phosphomonoesters | 3.22e-05 | 37 | 200 | 5 | GO:0016891 | |
| GeneOntologyMolecularFunction | aspartic-type endopeptidase activity | 3.22e-05 | 37 | 200 | 5 | GO:0004190 | |
| GeneOntologyMolecularFunction | aspartic-type peptidase activity | 3.68e-05 | 38 | 200 | 5 | GO:0070001 | |
| GeneOntologyMolecularFunction | myosin V binding | 4.17e-05 | 20 | 200 | 4 | GO:0031489 | |
| GeneOntologyMolecularFunction | calcium channel activity | 4.77e-05 | 129 | 200 | 8 | GO:0005262 | |
| GeneOntologyMolecularFunction | GTP-dependent protein binding | 8.87e-05 | 24 | 200 | 4 | GO:0030742 | |
| GeneOntologyMolecularFunction | endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters | 9.41e-05 | 46 | 200 | 5 | GO:0016893 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 9.41e-05 | 46 | 200 | 5 | GO:0005245 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.44e-04 | 151 | 200 | 8 | GO:0015085 | |
| GeneOntologyMolecularFunction | iron ion transmembrane transporter activity | 1.54e-04 | 11 | 200 | 3 | GO:0005381 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on a nucleic acid | ERVK-6 ERVK-7 ERVK-10 RUVBL2 WARS2 GGT3P PAN2 TFB2M ERVK-11 PUS7 TERF2 GGT2P DARS2 TEFM YARS2 MLH3 ERVK-8 | 2.80e-04 | 645 | 200 | 17 | GO:0140640 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on phosphorus or arsenic in donors | 2.97e-04 | 3 | 200 | 2 | GO:0030613 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor | 2.97e-04 | 3 | 200 | 2 | GO:0030614 | |
| GeneOntologyMolecularFunction | cadmium ion transmembrane transporter activity | 2.97e-04 | 3 | 200 | 2 | GO:0015086 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 2.97e-04 | 3 | 200 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on RNA | ERVK-6 ERVK-7 ERVK-10 WARS2 GGT3P PAN2 TFB2M ERVK-11 PUS7 GGT2P DARS2 YARS2 ERVK-8 | 3.10e-04 | 417 | 200 | 13 | GO:0140098 |
| GeneOntologyMolecularFunction | peptidase activity | ERVK-6 ERVK-7 ERVK-10 GGT3P MALT1 ERVK-18 USP7 PAN2 MMP14 COPS6 GGT2P USP21 USP40 ERVK-8 EIF3H CFAP44 ECE2 | 3.28e-04 | 654 | 200 | 17 | GO:0008233 |
| GeneOntologyMolecularFunction | ryanodine-sensitive calcium-release channel activity | 5.91e-04 | 4 | 200 | 2 | GO:0005219 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | TRPM6 RYR1 RYR3 ITPR1 SCN10A CACNA1I CACNA1G CALHM5 TMC1 TMC2 KCNAB2 | 7.11e-04 | 343 | 200 | 11 | GO:0005261 |
| GeneOntologyMolecularFunction | intracellularly gated calcium channel activity | 7.23e-04 | 18 | 200 | 3 | GO:0015278 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 7.23e-04 | 18 | 200 | 3 | GO:0008569 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | TRPM6 RYR1 RYR3 ITPR1 SCN10A CACNA1I CACNA1G TMC1 SLC11A2 TMC2 KCNAB2 SLC40A1 SLC11A1 | 8.59e-04 | 465 | 200 | 13 | GO:0046873 |
| GeneOntologyMolecularFunction | nucleotidyltransferase activity | 8.66e-04 | 152 | 200 | 7 | GO:0016779 | |
| GeneOntologyMolecularFunction | glutathione disulfide oxidoreductase activity | 9.79e-04 | 5 | 200 | 2 | GO:0015038 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.19e-03 | 79 | 200 | 5 | GO:0004521 | |
| GeneOntologyMolecularFunction | catalytic activity, acting on DNA | 1.34e-03 | 262 | 200 | 9 | GO:0140097 | |
| GeneOntologyMolecularFunction | peptidyltransferase activity | 1.46e-03 | 6 | 200 | 2 | GO:0000048 | |
| GeneOntologyMolecularFunction | ferrous iron transmembrane transporter activity | 1.46e-03 | 6 | 200 | 2 | GO:0015093 | |
| GeneOntologyMolecularFunction | leukotriene-C(4) hydrolase | 1.46e-03 | 6 | 200 | 2 | GO:0002951 | |
| GeneOntologyMolecularFunction | calcium-induced calcium release activity | 1.46e-03 | 6 | 200 | 2 | GO:0048763 | |
| GeneOntologyMolecularFunction | small GTPase binding | MYO5A MYO5B ANKFY1 DOCK9 RAPGEF4 DOCK10 XPO1 DOCK7 DAAM1 ACAP2 | 1.53e-03 | 321 | 200 | 10 | GO:0031267 |
| GeneOntologyMolecularFunction | deubiquitinase activity | 1.57e-03 | 124 | 200 | 6 | GO:0101005 | |
| GeneOntologyMolecularFunction | myosin binding | 1.64e-03 | 85 | 200 | 5 | GO:0017022 | |
| GeneOntologyMolecularFunction | 7S RNA binding | 2.03e-03 | 7 | 200 | 2 | GO:0008312 | |
| GeneOntologyMolecularFunction | gated channel activity | RYR1 RYR3 ITPR1 SCN10A CACNA1I CACNA1G TMC1 TMC2 KCNAB2 ANO3 | 2.05e-03 | 334 | 200 | 10 | GO:0022836 |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 2.17e-03 | 26 | 200 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | TRPM6 RYR1 RYR3 ITPR1 SCN10A CACNA1I CACNA1G CALHM5 TMC1 TMC2 KCNAB2 ANO3 | 2.36e-03 | 459 | 200 | 12 | GO:0005216 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.44e-03 | 182 | 200 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | RNA nuclease activity | 2.51e-03 | 136 | 200 | 6 | GO:0004540 | |
| GeneOntologyMolecularFunction | endonuclease activity | 2.51e-03 | 136 | 200 | 6 | GO:0004519 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.59e-03 | 184 | 200 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 2.60e-03 | 137 | 200 | 6 | GO:0019783 | |
| GeneOntologyMolecularFunction | leukotriene C4 gamma-glutamyl transferase activity | 2.69e-03 | 8 | 200 | 2 | GO:0103068 | |
| GeneOntologyMolecularFunction | cobalt ion binding | 2.69e-03 | 8 | 200 | 2 | GO:0050897 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.70e-03 | 28 | 200 | 3 | GO:0051959 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | TRPM6 RYR1 RYR3 ITPR1 SCN10A CACNA1I CACNA1G CALHM5 TMC1 SLC11A2 TMC2 KCNAB2 SLC40A1 ATP6V1H SLC11A1 | 2.90e-03 | 664 | 200 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | catalytic activity, acting on a tRNA | 3.33e-03 | 144 | 200 | 6 | GO:0140101 | |
| GeneOntologyMolecularFunction | glutathione hydrolase activity | 3.43e-03 | 9 | 200 | 2 | GO:0036374 | |
| GeneOntologyMolecularFunction | GTPase binding | MYO5A MYO5B ANKFY1 DOCK9 RAPGEF4 DOCK10 XPO1 DOCK7 DAAM1 ACAP2 | 3.51e-03 | 360 | 200 | 10 | GO:0051020 |
| GeneOntologyMolecularFunction | ligand-gated calcium channel activity | 3.62e-03 | 31 | 200 | 3 | GO:0099604 | |
| GeneOntologyBiologicalProcess | DNA integration | 9.85e-08 | 13 | 200 | 5 | GO:0015074 | |
| GeneOntologyBiologicalProcess | regulation of vesicle-mediated transport | MYO5A MYO5B RAB3C AP2A1 SNAP91 MTMR2 USP7 C3 CACNA1I CACNA1G RAB3A RAB3B ANKFY1 RAPGEF4 TOR1A RAB3D MSN SLC11A1 CD47 PRKCB | 8.24e-06 | 667 | 200 | 20 | GO:0060627 |
| GeneOntologyBiologicalProcess | iron ion transmembrane transport | 9.54e-06 | 30 | 200 | 5 | GO:0034755 | |
| GeneOntologyBiologicalProcess | synaptic vesicle cycle | MYO5B EPS15L1 PLAA AP2A1 SNAP91 RAB3A RAB3B RAPGEF4 TOR1A ATP6V1H ITSN2 PRKCB | 1.09e-05 | 264 | 200 | 12 | GO:0099504 |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling | 1.28e-05 | 111 | 200 | 8 | GO:0036465 | |
| GeneOntologyBiologicalProcess | iron ion transport | 4.71e-05 | 67 | 200 | 6 | GO:0006826 | |
| GeneOntologyBiologicalProcess | tRNA aminoacylation for mitochondrial protein translation | 4.85e-05 | 8 | 200 | 3 | GO:0070127 | |
| GeneOntologyBiologicalProcess | DNA-templated DNA replication | ERVK-6 ERVK-7 ERVK-10 ERVK-11 MMS22L TERF2 TEFM DNAJA3 ERVK-8 | 6.22e-05 | 178 | 200 | 9 | GO:0006261 |
| GeneOntologyBiologicalProcess | vesicle-mediated transport in synapse | MYO5B EPS15L1 PLAA AP2A1 SNAP91 RAB3A RAB3B RAPGEF4 TOR1A ATP6V1H ITSN2 PRKCB | 7.41e-05 | 321 | 200 | 12 | GO:0099003 |
| GeneOntologyBiologicalProcess | regulation of exocytosis | MYO5A MYO5B RAB3C CACNA1I CACNA1G RAB3A RAB3B RAPGEF4 RAB3D PRKCB | 9.66e-05 | 233 | 200 | 10 | GO:0017157 |
| GeneOntologyBiologicalProcess | DNA synthesis involved in DNA repair | 9.95e-05 | 48 | 200 | 5 | GO:0000731 | |
| GeneOntologyBiologicalProcess | RNA-templated DNA biosynthetic process | 1.57e-04 | 83 | 200 | 6 | GO:0006278 | |
| GeneOntologyBiologicalProcess | mitochondrial RNA metabolic process | 1.75e-04 | 54 | 200 | 5 | GO:0000959 | |
| GeneOntologyCellularComponent | transport vesicle | MYO5A VPS45 COPB2 RAB3C ITPR1 AP2A1 SNAP91 MTMR2 RAB3A RAB3B TOR1A RAB3D SLC40A1 ATP6V1H USO1 NRSN1 ECE2 | 1.04e-05 | 519 | 199 | 17 | GO:0030133 |
| GeneOntologyCellularComponent | presynapse | MYO5A VPS45 RAB3C ITPR1 EPS15L1 NF1 PIAS3 SNAP91 SCN10A MTMR2 RAB3A RAB3B RAPGEF4 KCNAB2 TOR1A RAB3D SLC40A1 CRMP1 ATP6V1H ITSN2 CD47 PRKCB | 3.98e-05 | 886 | 199 | 22 | GO:0098793 |
| GeneOntologyCellularComponent | calcium channel complex | 6.92e-05 | 73 | 199 | 6 | GO:0034704 | |
| GeneOntologyCellularComponent | smooth endoplasmic reticulum | 7.42e-05 | 46 | 199 | 5 | GO:0005790 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 7.42e-05 | 46 | 199 | 5 | GO:0005891 | |
| GeneOntologyCellularComponent | synaptic vesicle | MYO5A VPS45 RAB3C SNAP91 MTMR2 RAB3A RAB3B TOR1A RAB3D SLC40A1 ATP6V1H | 1.49e-04 | 300 | 199 | 11 | GO:0008021 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | MYO5B RAB3C RYR1 GGT3P RYR3 ITPR1 MALT1 MTMR2 PKHD1 CACNA1G COPS6 RAB3A RAB3B SLC11A2 ARFGEF1 ABCC5 GGT2P MSN USO1 DAAM1 MX1 | 2.38e-04 | 934 | 199 | 21 | GO:0048471 |
| GeneOntologyCellularComponent | exocytic vesicle | MYO5A VPS45 RAB3C SNAP91 MTMR2 RAB3A RAB3B TOR1A RAB3D SLC40A1 ATP6V1H | 2.61e-04 | 320 | 199 | 11 | GO:0070382 |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 5.24e-04 | 17 | 199 | 3 | GO:0001518 | |
| GeneOntologyCellularComponent | cytoplasmic vesicle membrane | MYO5B VPS45 COPB2 RAB3C ITPR1 AP2A1 SNAP91 MTMR2 RAB3A RAB3B MRC1 FLT3 ANKFY1 SLC11A2 KCNAB2 TOR1A RAB3D ABCC5 ATP6V1H SLC11A1 USO1 CD47 CD68 ACAP2 ECE2 | 6.89e-04 | 1307 | 199 | 25 | GO:0030659 |
| GeneOntologyCellularComponent | nuclear chromosome | 7.61e-04 | 254 | 199 | 9 | GO:0000228 | |
| GeneOntologyCellularComponent | endosome | TPT1 MYO5A MYO5B VPS45 RAB3C MELTF AP2A1 SNAP91 MTMR2 MMP14 RAB3A RAB3B MRC1 FLT3 ANKFY1 SLC11A2 RAB3D ABCC5 ECPAS ATP6V1H SLC11A1 CD68 ACAP2 | 7.64e-04 | 1167 | 199 | 23 | GO:0005768 |
| GeneOntologyCellularComponent | vesicle membrane | MYO5B VPS45 COPB2 RAB3C ITPR1 AP2A1 SNAP91 MTMR2 RAB3A RAB3B MRC1 FLT3 ANKFY1 SLC11A2 KCNAB2 TOR1A RAB3D ABCC5 ATP6V1H SLC11A1 USO1 CD47 CD68 ACAP2 ECE2 | 8.38e-04 | 1325 | 199 | 25 | GO:0012506 |
| GeneOntologyCellularComponent | clathrin coat of coated pit | 9.96e-04 | 21 | 199 | 3 | GO:0030132 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 1.37e-03 | 223 | 199 | 8 | GO:0098862 | |
| Domain | ARM-type_fold | PDS5B TRRAP RYR3 ITPR1 NF1 PLAA AP2A1 DOCK9 RTTN ARFGEF1 XPO1 ECPAS VIRMA ATP6V1H USO1 DAAM1 | 4.66e-07 | 339 | 192 | 16 | IPR016024 |
| Domain | RIH_assoc-dom | 2.09e-05 | 6 | 192 | 3 | IPR013662 | |
| Domain | Ins145_P3_rec | 2.09e-05 | 6 | 192 | 3 | PF08709 | |
| Domain | DUF3398 | 2.09e-05 | 6 | 192 | 3 | PF11878 | |
| Domain | RIH_assoc | 2.09e-05 | 6 | 192 | 3 | PF08454 | |
| Domain | RIH_dom | 2.09e-05 | 6 | 192 | 3 | IPR000699 | |
| Domain | Ins145_P3_rcpt | 2.09e-05 | 6 | 192 | 3 | IPR014821 | |
| Domain | Ryanodine_recept-rel | 2.09e-05 | 6 | 192 | 3 | IPR015925 | |
| Domain | - | 2.09e-05 | 6 | 192 | 3 | 1.25.10.30 | |
| Domain | RYDR_ITPR | 2.09e-05 | 6 | 192 | 3 | PF01365 | |
| Domain | DOCK_C/D_N | 2.09e-05 | 6 | 192 | 3 | IPR021816 | |
| Domain | ARM-like | PDS5B TRRAP NF1 PLAA AP2A1 RTTN DOCK10 ARFGEF1 XPO1 ECPAS ATP6V1H DAAM1 | 2.40e-05 | 270 | 192 | 12 | IPR011989 |
| Domain | - | 1.04e-04 | 222 | 192 | 10 | 1.25.10.10 | |
| Domain | HIF-1a_CTAD | 1.05e-04 | 2 | 192 | 2 | PF08778 | |
| Domain | Nramp | 1.05e-04 | 2 | 192 | 2 | PF01566 | |
| Domain | NRAMP_fam | 1.05e-04 | 2 | 192 | 2 | IPR001046 | |
| Domain | HIF-1_TAD_C | 1.05e-04 | 2 | 192 | 2 | IPR014887 | |
| Domain | MIR | 1.22e-04 | 10 | 192 | 3 | PF02815 | |
| Domain | MIR_motif | 1.22e-04 | 10 | 192 | 3 | IPR016093 | |
| Domain | MIR | 1.22e-04 | 10 | 192 | 3 | PS50919 | |
| Domain | MIR | 1.22e-04 | 10 | 192 | 3 | SM00472 | |
| Domain | DHR-1_domain | 1.66e-04 | 11 | 192 | 3 | IPR027007 | |
| Domain | DHR_2 | 1.66e-04 | 11 | 192 | 3 | PS51651 | |
| Domain | DHR_1 | 1.66e-04 | 11 | 192 | 3 | PS51650 | |
| Domain | DHR-2 | 1.66e-04 | 11 | 192 | 3 | PF06920 | |
| Domain | DOCK | 1.66e-04 | 11 | 192 | 3 | IPR026791 | |
| Domain | DOCK_C | 1.66e-04 | 11 | 192 | 3 | IPR010703 | |
| Domain | DOCK-C2 | 1.66e-04 | 11 | 192 | 3 | PF14429 | |
| Domain | DHR-2 | 1.66e-04 | 11 | 192 | 3 | IPR027357 | |
| Domain | Ion_trans_dom | 1.77e-04 | 114 | 192 | 7 | IPR005821 | |
| Domain | Ion_trans | 1.77e-04 | 114 | 192 | 7 | PF00520 | |
| Domain | Ryanodine_rcpt | 3.13e-04 | 3 | 192 | 2 | IPR003032 | |
| Domain | VDCC_T_a1 | 3.13e-04 | 3 | 192 | 2 | IPR005445 | |
| Domain | Ryanrecept_TM4-6 | 3.13e-04 | 3 | 192 | 2 | IPR009460 | |
| Domain | HIF_alpha_subunit | 3.13e-04 | 3 | 192 | 2 | IPR021537 | |
| Domain | HIF-1 | 3.13e-04 | 3 | 192 | 2 | PF11413 | |
| Domain | RyR | 3.13e-04 | 3 | 192 | 2 | PF02026 | |
| Domain | RR_TM4-6 | 3.13e-04 | 3 | 192 | 2 | PF06459 | |
| Domain | Ryan_recept | 3.13e-04 | 3 | 192 | 2 | IPR013333 | |
| Domain | Lipocln_cytosolic_FA-bd_dom | 3.94e-04 | 34 | 192 | 4 | IPR000566 | |
| Domain | Lipocalin | 3.94e-04 | 34 | 192 | 4 | PF00061 | |
| Domain | - | 4.42e-04 | 35 | 192 | 4 | 2.40.128.20 | |
| Domain | iLBP | 5.43e-04 | 16 | 192 | 3 | IPR031259 | |
| Domain | Fatty_acid-bd | 5.43e-04 | 16 | 192 | 3 | IPR000463 | |
| Domain | FABP | 5.43e-04 | 16 | 192 | 3 | PS00214 | |
| Domain | Calycin-like | 5.48e-04 | 37 | 192 | 4 | IPR011038 | |
| Domain | Calycin | 5.48e-04 | 37 | 192 | 4 | IPR012674 | |
| Domain | aa-tRNA-synth_Ic | 6.22e-04 | 4 | 192 | 2 | IPR002305 | |
| Domain | tRNA-synt_1b | 6.22e-04 | 4 | 192 | 2 | PF00579 | |
| Domain | Myosin_S1_N | 1.03e-03 | 5 | 192 | 2 | IPR008989 | |
| Domain | Mab-21-like_1/2 | 1.03e-03 | 5 | 192 | 2 | IPR020950 | |
| Domain | Dilute_dom | 1.53e-03 | 6 | 192 | 2 | IPR002710 | |
| Domain | DIL | 1.53e-03 | 6 | 192 | 2 | PF01843 | |
| Domain | DILUTE | 1.53e-03 | 6 | 192 | 2 | PS51126 | |
| Domain | DIL | 1.53e-03 | 6 | 192 | 2 | SM01132 | |
| Pubmed | Rab3 superprimes synaptic vesicles for release: implications for short-term synaptic plasticity. | 1.10e-09 | 4 | 202 | 4 | 16436611 | |
| Pubmed | Rab3 proteins involved in vesicle biogenesis and priming in embryonic mouse chromaffin cells. | 1.10e-09 | 4 | 202 | 4 | 20716109 | |
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 12167638 | ||
| Pubmed | 1.10e-09 | 4 | 202 | 4 | 15269275 | ||
| Pubmed | Large-scale proteomics and phosphoproteomics of urinary exosomes. | MAN2A1 MYO5B BPIFB1 GSTO2 RYR1 FABP1 SIAE FAM20C MELTF HSPA12A SCN10A PKHD1 RAB3B DYNC1H1 ANKFY1 RBP5 RAB3D IDH1 SLC44A4 MSN CRYZ ATP6V1H ITSN2 PLEKHA1 EIF3H | 1.42e-09 | 1016 | 202 | 25 | 19056867 |
| Pubmed | Tctex-1, a novel interaction partner of Rab3D, is required for osteoclastic bone resorption. | 5.50e-09 | 5 | 202 | 4 | 21262767 | |
| Pubmed | 5.50e-09 | 5 | 202 | 4 | 11598194 | ||
| Pubmed | Noc2 is essential in normal regulation of exocytosis in endocrine and exocrine cells. | 5.50e-09 | 5 | 202 | 4 | 15159548 | |
| Pubmed | Identification and characterization of multiple novel Rab-myosin Va interactions. | 1.21e-08 | 14 | 202 | 5 | 24006491 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | DLGAP1 MYO5A UBE4B RAB3C NF1 AP2A1 RAB3A DYNC1H1 RASAL2 RAPGEF4 KCNAB2 CRMP1 PRKCB | 1.23e-08 | 281 | 202 | 13 | 28706196 |
| Pubmed | The RAB3-RIM Pathway Is Essential for the Release of Neuromodulators. | 1.64e-08 | 6 | 202 | 4 | 31679900 | |
| Pubmed | 1.64e-08 | 6 | 202 | 4 | 12192047 | ||
| Pubmed | Network organization of the huntingtin proteomic interactome in mammalian brain. | CDH26 MYO5A MYO5B TRRAP RAB3C ITPR1 EPS15L1 HSPA12A AP2A1 SNAP91 RAB3A RAB3B DYNC1H1 KCNAB2 RAB3D RPSA CRMP1 PRKCB | 2.86e-08 | 621 | 202 | 18 | 22794259 |
| Pubmed | Mono-ubiquitination of Rabphilin 3A by UBE3A serves a non-degradative function. | 3.81e-08 | 7 | 202 | 4 | 33542309 | |
| Pubmed | Rep15 interacts with several Rab GTPases and has a distinct fold for a Rab effector. | 3.81e-08 | 7 | 202 | 4 | 35871249 | |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | NPL ERVK-6 PDS5B BRINP3 ARID4B UBE4B BECN2 OR2W5P SLC66A1 WARS2 CASZ1 TFB2M RAB3B RASAL2 NTMT2 SZT2 KCNAB2 GLRX2 CPT2 RCAN3 NLRP3 DARS2 DOCK7 | 4.08e-08 | 1031 | 202 | 23 | 16710414 |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | PDS5B TRRAP RYR3 KMT2C USP7 CPSF1 PLCB4 COPS6 DOCK9 RAPGEF4 SMC4 XPO1 ECPAS RGS12 ANO3 HYDIN | 4.17e-08 | 497 | 202 | 16 | 36774506 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | TRPM6 PDS5B COPB2 SRP14 SRP72 SSR4 RUVBL2 NF1 AP2A1 USP7 CPSF1 DYNC1H1 RASAL2 ANKFY1 SMC4 UFL1 RPSA XPO1 ECPAS DARS2 YARS2 DNAJA3 ATP6V1H USO1 CD47 DOCK7 EIF3H | 7.14e-08 | 1425 | 202 | 27 | 30948266 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | COPB2 RYR1 FABP7 TMEM260 IGSF10 KMT2C FAM20C PKHD1 CPSF1 DYNC1H1 SIN3B NACC1 SMC4 ECPAS RCAN3 DARS2 GIMAP8 PRKCB CFAP44 | 7.15e-08 | 736 | 202 | 19 | 29676528 |
| Pubmed | DLGAP1 MYO5A MYO5B VPS45 COPB2 SRP72 EPS15L1 HSPA12A NF1 AP2A1 SNAP91 MTMR2 USP7 DYNC1H1 RASAL2 RAPGEF4 KCNAB2 RAB3D RPSA XPO1 VIRMA CRMP1 ATP6V1H USO1 ITSN2 DOCK7 PRKCB | 7.77e-08 | 1431 | 202 | 27 | 37142655 | |
| Pubmed | 1.93e-07 | 3 | 202 | 3 | 32742255 | ||
| Pubmed | DLGAP1 MYO5A RAB3C EPS15L1 NF1 AP2A1 SNAP91 RAB3A RAB3B DYNC1H1 RASAL2 SIN3B ANKFY1 NACC1 RAPGEF4 KCNAB2 VIRMA CRMP1 MSN DOCK7 PRKCB | 2.39e-07 | 963 | 202 | 21 | 28671696 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | PDS5B CYP2B6 ANKS6 MYO5A STIMATE BPIFB1 GSTO2 TRRAP C3orf20 NF1 ADGRD1 RASAL2 MMS22L TMC1 UFL1 MYRFL CPT2 VIRMA DARS2 USP21 DNAH17 EIF3H MX1 LRRC71 | 2.85e-07 | 1242 | 202 | 24 | 30973865 |
| Pubmed | PDS5B MYO5A COPB2 SRP72 TRRAP NF1 USP7 CPSF1 DYNC1H1 SMC4 BEND3 RPSA XPO1 ECPAS VIRMA MSN DOCK7 | 3.20e-07 | 653 | 202 | 17 | 22586326 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 7.22e-07 | 220 | 202 | 10 | 35785414 | |
| Pubmed | Ryanodine receptor calcium release channels: lessons from structure-function studies. | 7.69e-07 | 4 | 202 | 3 | 23413940 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 9607712 | ||
| Pubmed | Many human endogenous retrovirus K (HERV-K) proviruses are unique to humans. | 7.69e-07 | 4 | 202 | 3 | 10469592 | |
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 33789996 | ||
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 20952238 | ||
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 11431472 | ||
| Pubmed | 7.69e-07 | 4 | 202 | 3 | 16278385 | ||
| Pubmed | DLGAP1 MYO5A VPS45 COPB2 RUVBL2 ITPR1 FABP7 EPS15L1 HSPA12A NF1 PLAA USP7 PIP4K2B RAB3A DOCK9 KCNAB2 RPSA MSN DNAJA3 DOCK7 PRKCB DAAM1 | 9.32e-07 | 1139 | 202 | 22 | 36417873 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | PDS5B MYO5A UBE4B PSMB4 COPB2 SRP14 SSR4 TRRAP RUVBL2 NF1 PLAA AP2A1 USP7 CPSF1 MMP14 DYNC1H1 RASAL2 ANKFY1 SMC4 DOCK10 RPSA XPO1 MSN DNAJA3 | 1.30e-06 | 1353 | 202 | 24 | 29467282 |
| Pubmed | PSMB4 COPB2 SSR4 NF1 TFB2M MMS22L SMC4 TOR1A ARFGEF1 RPSA XPO1 ECPAS DNAJA3 ATP6V1H EIF3H ACAP2 | 1.71e-06 | 657 | 202 | 16 | 36180527 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 30352047 | ||
| Pubmed | Quantitation of HERV-K env gene expression and splicing in human breast cancer. | 1.91e-06 | 5 | 202 | 3 | 12629516 | |
| Pubmed | 1.91e-06 | 5 | 202 | 3 | 17477366 | ||
| Pubmed | DLGAP1 MYO5A RAB3C RAB3A RAB3B DYNC1H1 RASAL2 RAPGEF4 KCNAB2 PRKCB | 2.37e-06 | 251 | 202 | 10 | 27507650 | |
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 2.70e-06 | 38 | 202 | 5 | 30786075 | |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | COPB2 SRP72 RUVBL2 PLAA USP7 CPSF1 C3 NCEH1 ANKFY1 IDH1 XPO1 ECPAS VIRMA DARS2 CRYZ | 3.05e-06 | 607 | 202 | 15 | 39147351 |
| Pubmed | Essential Roles of Intracellular Calcium Release Channels in Muscle, Brain, Metabolism, and Aging. | 3.81e-06 | 6 | 202 | 3 | 25966694 | |
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 20519450 | ||
| Pubmed | 3.81e-06 | 6 | 202 | 3 | 23463619 | ||
| Pubmed | IP3Rs are sufficient for dendritic cell Ca2+ signaling in the absence of RyR1. | 3.81e-06 | 6 | 202 | 3 | 16844763 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | MYO5A PSMB4 COPB2 SRP14 RUVBL2 AP2A1 USP7 COPS6 DYNC1H1 NACC1 SMC4 RPSA IDH1 XPO1 ECPAS CPT2 MSN DNAJA3 USO1 DOCK7 EIF3H | 3.95e-06 | 1149 | 202 | 21 | 35446349 |
| Pubmed | 4.00e-06 | 19 | 202 | 4 | 16787915 | ||
| Pubmed | 4.05e-06 | 72 | 202 | 6 | 36376293 | ||
| Pubmed | COPB2 SRP14 SRP72 RUVBL2 EPS15L1 DYNC1H1 RASAL2 SMC4 ABCC5 XPO1 ECPAS MSN ATP6V1H USO1 DOCK7 PLEKHA1 | 4.43e-06 | 708 | 202 | 16 | 39231216 | |
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | UBE4B PSMB4 COPB2 SRP14 SRP72 RUVBL2 EPS15L1 PLAA MTMR2 USP7 COPS6 DYNC1H1 PUS7 ANKFY1 SMC4 RPSA IDH1 XPO1 ECPAS CRMP1 MSN CRYZ ATP6V1H EIF3H | 4.50e-06 | 1455 | 202 | 24 | 22863883 |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | PDS5B TPT1 COPB2 SRP14 SSR4 TRRAP RUVBL2 MALT1 KMT2C USP7 DYNC1H1 RASAL2 MMS22L SMC4 TOR1A UFL1 ECPAS YARS2 MSN NDUFAF1 USO1 EIF3H | 6.40e-06 | 1284 | 202 | 22 | 17353931 |
| Pubmed | The 8-kDa dynein light chain binds to its targets via a conserved (K/R)XTQT motif. | 6.64e-06 | 7 | 202 | 3 | 11148209 | |
| Pubmed | 6.64e-06 | 7 | 202 | 3 | 11860456 | ||
| Pubmed | MYO5A PSMB4 COPB2 SSR4 EPS15L1 AP2A1 USP7 CPSF1 ANKFY1 DOCK9 SMC4 DOCK10 XPO1 ECPAS VIRMA MSN ITSN2 DOCK7 | 7.59e-06 | 916 | 202 | 18 | 32203420 | |
| Pubmed | 1.07e-05 | 24 | 202 | 4 | 31911859 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | PDS5B UBE4B PSMB4 COPB2 SRP72 SSR4 PLAA AP2A1 RFT1 DYNC1H1 SMC4 ARFGEF1 UFL1 XPO1 ECPAS DARS2 ATP6V1H USO1 | 1.11e-05 | 942 | 202 | 18 | 31073040 |
| Pubmed | Rab18 and a Rab18 GEF complex are required for normal ER structure. | 1.58e-05 | 9 | 202 | 3 | 24891604 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | TPT1 PSMB4 COPB2 RUVBL2 EPS15L1 PLAA AP2A1 COPS6 PUS7 SIN3B RBM11 SMC4 ARFGEF1 RPSA IDH1 XPO1 ECPAS YARS2 MSN CRYZ ATP6V1H USO1 | 1.69e-05 | 1367 | 202 | 22 | 32687490 |
| Pubmed | A revised nomenclature for transcribed human endogenous retroviral loci. | 1.90e-05 | 94 | 202 | 6 | 21542922 | |
| Pubmed | PDS5B MAN2A1 COPB2 SRP72 RUVBL2 KMT2C USP7 C3 DYNC1H1 UFL1 RPSA IDH1 XPO1 ECPAS DNAJA3 | 1.98e-05 | 711 | 202 | 15 | 33022573 | |
| Pubmed | 2.24e-05 | 58 | 202 | 5 | 11856727 | ||
| Pubmed | MYO5A PSMB4 SRP72 RUVBL2 USP7 DYNC1H1 SMC4 UFL1 XPO1 USO1 DOCK7 | 2.43e-05 | 399 | 202 | 11 | 37536630 | |
| Pubmed | The ubiquitin-dependent ATPase p97 removes cytotoxic trapped PARP1 from chromatin. | MYO5B AP2A1 USP7 TFB2M RPSA CPT2 VIRMA DNAJA3 ATP6V1H USO1 DOCK7 | 2.48e-05 | 400 | 202 | 11 | 35013556 |
| Pubmed | ∆F508 CFTR interactome remodelling promotes rescue of cystic fibrosis. | PSMB4 COPB2 SRP14 SSR4 RUVBL2 C3 NCEH1 RAB3B DYNC1H1 SMC4 XPO1 MSN DAAM1 MX1 | 2.86e-05 | 647 | 202 | 14 | 26618866 |
| Pubmed | 3.02e-05 | 102 | 202 | 6 | 9734811 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23437279 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26746864 | ||
| Pubmed | Loss of either hypoxia inducible factor 1 or 2 promotes lung cancer cell colonization. | 3.36e-05 | 2 | 202 | 2 | 21610325 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26758827 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 25046225 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 26531845 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20007457 | ||
| Pubmed | Mutation analysis of hypoxia-inducible factors HIF1A and HIF2A in renal cell carcinoma. | 3.36e-05 | 2 | 202 | 2 | 20032376 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 36482296 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 29082606 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 30140083 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 24726658 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17437013 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23871232 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 9489997 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17562539 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17718430 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 17804822 | ||
| Pubmed | Intestinal expression of genes involved in iron absorption in humans. | 3.36e-05 | 2 | 202 | 2 | 11897618 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20005221 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 20140661 | ||
| Pubmed | Both Nramp1 and DMT1 are necessary for efficient macrophage iron recycling. | 3.36e-05 | 2 | 202 | 2 | 20394798 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 34740372 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 25805230 | ||
| Pubmed | Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. | 3.36e-05 | 2 | 202 | 2 | 29258297 | |
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 23303559 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 19439736 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 19123465 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 33321829 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 18419598 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 31548403 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 28232488 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 16263938 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 16826581 | ||
| Pubmed | 3.36e-05 | 2 | 202 | 2 | 16611993 | ||
| Interaction | RIMS2 interactions | 1.68e-07 | 27 | 191 | 6 | int:RIMS2 | |
| Interaction | USP9X interactions | TPT1 DLGAP1 HIF1A ARID4B UBE4B PSMB4 MALT1 USP7 COPS6 FLT3 XPO1 ECPAS TERF2 VIRMA NLRP3 PRKCB GPSM1 | 6.01e-07 | 422 | 191 | 17 | int:USP9X |
| Interaction | REP15 interactions | 1.31e-06 | 21 | 191 | 5 | int:REP15 | |
| Interaction | EED interactions | PDS5B TPT1 MAN2A1 ARID4B PHF19 MYO5B UBE4B VPS45 COPB2 SRP14 SSR4 TRRAP RUVBL2 CASZ1 EPS15L1 AP2A1 USP7 CPSF1 DYNC1H1 RBM11 ANKFY1 SZT2 SMC4 RPSA XPO1 VIRMA AR USP21 ATP6V1H USO1 ITSN2 EIF3H | 5.76e-06 | 1445 | 191 | 32 | int:EED |
| Interaction | CD80 interactions | 1.00e-05 | 79 | 191 | 7 | int:CD80 | |
| Interaction | BPNT2 interactions | 1.47e-05 | 56 | 191 | 6 | int:BPNT2 | |
| Interaction | FBXO22 interactions | PDS5B TRRAP RYR3 KMT2C USP7 CPSF1 PHLPP1 PLCB4 COPS6 DOCK9 RAPGEF4 SMC4 XPO1 ECPAS RGS12 ANO3 HYDIN | 1.61e-05 | 540 | 191 | 17 | int:FBXO22 |
| Interaction | LAMP2 interactions | PDS5B HIF1A MYO5A VPS45 SRP14 SIAE HSPA12A AP2A1 NCEH1 TFB2M RAB3B SLC11A2 SZT2 ARFGEF1 MSN ATP6V1H CD47 PLEKHA1 | 2.10e-05 | 609 | 191 | 18 | int:LAMP2 |
| Interaction | KCNA3 interactions | COPB2 SRP14 SRP72 RUVBL2 RYR1 KMT2C EPS15L1 PKHD1 DYNC1H1 RASAL2 SZT2 KCNAB2 SMC4 DOCK10 ABCC5 XPO1 ECPAS MSN ATP6V1H USO1 DOCK7 PLEKHA1 | 2.82e-05 | 871 | 191 | 22 | int:KCNA3 |
| Interaction | RPH3A interactions | 3.22e-05 | 39 | 191 | 5 | int:RPH3A | |
| Interaction | AGAP2 interactions | DLGAP1 MYO5A UBE4B NF1 AP2A1 DYNC1H1 RASAL2 RAPGEF4 CRMP1 PRKCB | 3.32e-05 | 210 | 191 | 10 | int:AGAP2 |
| Interaction | RIMS1 interactions | 3.65e-05 | 40 | 191 | 5 | int:RIMS1 | |
| Interaction | MYPN interactions | 3.65e-05 | 40 | 191 | 5 | int:MYPN | |
| Interaction | VRTN interactions | 4.12e-05 | 21 | 191 | 4 | int:VRTN | |
| Interaction | MACROD2 interactions | 4.53e-05 | 8 | 191 | 3 | int:MACROD2 | |
| Interaction | LIMA1 interactions | TPT1 MYO5A MYO5B NF1 AP2A1 USP7 PAN2 PHLPP1 RASAL2 UFL1 RPSA VIRMA USP21 EIF3H | 6.30e-05 | 429 | 191 | 14 | int:LIMA1 |
| Interaction | SHANK3 interactions | DLGAP1 MYO5A MYO5B ITPR1 NF1 SNAP91 COPS6 RAB3B DYNC1H1 RAPGEF4 KCNAB2 VIRMA DNAJA3 USO1 PRKCB | 8.10e-05 | 496 | 191 | 15 | int:SHANK3 |
| Interaction | ZFHX3 interactions | 8.12e-05 | 109 | 191 | 7 | int:ZFHX3 | |
| Interaction | OR8U1 interactions | 8.94e-05 | 2 | 191 | 2 | int:OR8U1 | |
| Interaction | ASMT interactions | 8.94e-05 | 2 | 191 | 2 | int:ASMT | |
| GeneFamily | Myosins, class V | 1.49e-04 | 3 | 128 | 2 | 1100 | |
| GeneFamily | Ryanodine receptors|Protein phosphatase 1 regulatory subunits | 1.49e-04 | 3 | 128 | 2 | 287 | |
| GeneFamily | Fatty acid binding protein family | 1.81e-04 | 16 | 128 | 3 | 550 | |
| GeneFamily | Ubiquitin specific peptidases | 6.62e-04 | 56 | 128 | 4 | 366 | |
| GeneFamily | RAB, member RAS oncogene GTPases | 1.16e-03 | 65 | 128 | 4 | 388 | |
| GeneFamily | Transmembrane channel likes | 1.35e-03 | 8 | 128 | 2 | 1135 | |
| GeneFamily | BEN domain containing | 1.73e-03 | 9 | 128 | 2 | 422 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.49e-03 | 206 | 128 | 6 | 682 | |
| GeneFamily | CD molecules|Gamma-glutamyltransferases | 3.69e-03 | 13 | 128 | 2 | 564 | |
| Coexpression | GSE25123_CTRL_VS_IL4_STIM_MACROPHAGE_DN | 1.86e-05 | 199 | 194 | 9 | M7924 | |
| Coexpression | GSE24292_WT_VS_PPARG_KO_MACROPHAGE_UP | 1.93e-05 | 200 | 194 | 9 | M8053 | |
| Coexpression | GSE40273_GATA1_KO_VS_WT_TREG_DN | 1.93e-05 | 200 | 194 | 9 | M9133 | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231|Adult / Lineage, Cell type, age group and donor | NPL HIF1A MYO5A SAMSN1 RYR1 MALT1 MRC1 AOAH ABCC5 NLRP3 PRKCB | 9.98e-10 | 194 | 194 | 11 | 800d3d7a9e864d2d6a100a4e4af22f45d5790a8d |
| ToppCell | Children_(3_yrs)-Immune|Children_(3_yrs) / Lineage, Cell type, age group and donor | NPL MYO5A SAMSN1 NCEH1 MRC1 AOAH KCNAB2 DOCK10 SLC11A1 CD68 PRKCB | 1.17e-09 | 197 | 194 | 11 | f18807124b91310fcd84238484a80ecdba684679 |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|lung / Disease (COVID-19 only), tissue and cell type | NPL MYO5A SAMSN1 SIGLEC10 MRC1 FLT3 AOAH KCNAB2 DOCK10 SLC11A1 PRKCB | 1.17e-09 | 197 | 194 | 11 | 3896729740d151f0eb845f1961c7b969bfbdd28d |
| ToppCell | Severe_COVID-19-Myeloid-MoAM4|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30） | NPL MYO5A FAM20C NCEH1 MMP14 MRC1 ABCC5 IDH1 SLC11A1 CD68 EPAS1 | 1.38e-09 | 200 | 194 | 11 | 30448a41ca64d6f0fedaff0b7a6670dd33cdf2c5 |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NPL MYO5A FAM20C NCEH1 MMP14 MRC1 ABCC5 IDH1 SLC11A1 CD68 EPAS1 | 1.38e-09 | 200 | 194 | 11 | 4f481d87e30195365900acb5d50641a9e7b2f462 |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | SAMSN1 MRC1 FLT3 AOAH KCNAB2 DOCK10 NLRP3 GIMAP8 SLC11A1 PRKCB NRSN1 | 1.38e-09 | 200 | 194 | 11 | 48ce43a27e78b2883e588e1a63fa5352c2deeeb7 |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | NPL MYO5A FAM20C NCEH1 MMP14 MRC1 ABCC5 IDH1 SLC11A1 CD68 EPAS1 | 1.38e-09 | 200 | 194 | 11 | cf720d3973e79ffd4c6e763a7284799ced22a274 |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | NPL MYO5A FAM20C NCEH1 MMP14 MRC1 ABCC5 IDH1 SLC11A1 CD68 EPAS1 | 1.38e-09 | 200 | 194 | 11 | 5490393c5f54748f912676e19b58bd1320415a06 |
| ToppCell | BAL-Severe-Myeloid-MoAM-MoAM4|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | NPL MYO5A FAM20C NCEH1 MMP14 MRC1 ABCC5 IDH1 SLC11A1 CD68 EPAS1 | 1.38e-09 | 200 | 194 | 11 | df821ac12953e44fcfedbbefb35a4976e406ccd6 |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-08 | 194 | 194 | 10 | 663e7e7fe48157e808b4f1a0ea6ad41944e857a2 | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | NPL MYO5A SAMSN1 MRC1 AOAH KCNAB2 DOCK10 NLRP3 SLC11A1 PRKCB | 1.53e-08 | 195 | 194 | 10 | ba7f85e5307d96ac5ad7c952f8d094db9ca1790c |
| ToppCell | background-Kupffer_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | MYO5A SAMSN1 SIGLEC10 MRC1 AOAH KCNAB2 SLC40A1 CD68 PRKCB TMEM26 | 1.68e-08 | 197 | 194 | 10 | 8b45c7ecc18d188abc8c172d9bf881c95617a46a |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | SAMSN1 SIGLEC10 MRC1 FLT3 AOAH KCNAB2 DOCK10 NLRP3 SLC11A1 PRKCB | 1.68e-08 | 197 | 194 | 10 | 72cd61b868d57862ec9c230ea68913d3829b0f2b |
| ToppCell | TCGA-Skin-Metastatic-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | ARID4B SAMSN1 ITPR1 SIGLEC10 C3 RBP5 AOAH SMC4 SLC40A1 GIMAP8 | 1.77e-08 | 198 | 194 | 10 | af4fb9eb2295c7b90624b38ba25619aa15254efa |
| ToppCell | COVID-19-kidney-Macrophages|kidney / Disease (COVID-19 only), tissue and cell type | NPL SAMSN1 SIGLEC10 MRC1 AOAH DOCK10 NLRP3 SLC11A1 CD68 PRKCB | 1.77e-08 | 198 | 194 | 10 | 161324541fe5da5cbb58142ea94fefd39b7dfb04 |
| ToppCell | Immune|World / Lineage, Cell type, age group and donor | 1.77e-08 | 198 | 194 | 10 | 65681b54d13c6997bd90a1c2a12314a80e964fe3 | |
| ToppCell | TCGA-Skin-Metastatic|TCGA-Skin / Sample_Type by Project: Shred V9 | ARID4B SAMSN1 ITPR1 SIGLEC10 C3 RBP5 AOAH SMC4 SLC40A1 GIMAP8 | 1.77e-08 | 198 | 194 | 10 | ad39cce004867f083f8da1954e0cf5a263815184 |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | NPL MYO5A DYRK4 SLC66A1 FAM20C HEXA-AS1 MRC1 KCNAB2 ABCC5 SLC11A1 | 1.77e-08 | 198 | 194 | 10 | 6a4161680b46b2c12353a693c403b5a4bb3da03f |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | ARID4B SAMSN1 ITPR1 SIGLEC10 C3 RBP5 AOAH SMC4 SLC40A1 GIMAP8 | 1.77e-08 | 198 | 194 | 10 | 62cbf4b29e8af4983fb47a17f96da62682a5137e |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.95e-08 | 175 | 194 | 9 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 190 | 194 | 9 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | Children_(3_yrs)-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.60e-07 | 190 | 194 | 9 | 0e9847d7f49b2236b8a191e1a7df37556351ba9e | |
| ToppCell | human_hepatoblastoma-Inflammatory_Monocytes|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.68e-07 | 191 | 194 | 9 | 3b59bfc6c106ae8a3fbcd4a74bd128c485724921 | |
| ToppCell | Immune-interstitial_macrophage_(C1Q_positive)|World / Lineage, Cell type, age group and donor | 1.83e-07 | 193 | 194 | 9 | 64d598162a256ac6c9f8280c8a9133661dfbb10f | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-07 | 194 | 194 | 9 | 1dce6d4b6ac41f80677e3e4c335a4f383bd76f85 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|lung / Disease (COVID-19 only), tissue and cell type | 2.00e-07 | 195 | 194 | 9 | 148fff8c3c9ba45ec36e98dff1be57e3f8294506 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-07 | 196 | 194 | 9 | 1b7928f4eee94d4bb6ea410bab68a471dba12979 | |
| ToppCell | COVID-19-lung-Macrophage_CD163hi_MERTKhi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.09e-07 | 196 | 194 | 9 | 7026c1fc33425e5476063d17c79e4b79356a9e01 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Monocytic-Monocyte-derived_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-07 | 197 | 194 | 9 | dea1d29154c585ab588e50b83c7c8de7fe24d2d4 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.18e-07 | 197 | 194 | 9 | 8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5 | |
| ToppCell | COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.18e-07 | 197 | 194 | 9 | e42910a653a1b5bd90c090e9665a84871ed2873f | |
| ToppCell | Fetal_29-31_weeks-Immune|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.27e-07 | 198 | 194 | 9 | 5dff131356b8c22743bd27b2b21f86ee6e4a0a0d | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma-stromal_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.37e-07 | 199 | 194 | 9 | 2649afa3ccda78e9d1df26127b66cbfa0c6cd01d | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid-Microglia|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-07 | 199 | 194 | 9 | 4ddfbcaa8054b69b3398d8c0d5fab8ae94805cb9 | |
| ToppCell | background-Kupffer_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 2.37e-07 | 199 | 194 | 9 | 91d229f3515d49639bcb5505e6aec4a9abade81c | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW23-Myeloid|GW23 / Sample Type, Dataset, Time_group, and Cell type. | 2.37e-07 | 199 | 194 | 9 | 3ba48a4715d5e9387650aa97e0c5d7f7897bf380 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.48e-07 | 200 | 194 | 9 | ad7ae5106141669b353800fece833b3cd5bdccee | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Glia_progenitor_cell|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.48e-07 | 200 | 194 | 9 | 6c1b7b0f3cd35d8cfee181ea83c73127dbc41ac5 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic-leukocyte|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-07 | 163 | 194 | 8 | 2f32a9ab0230fdca98ffa7fd59397301d50e4f30 | |
| ToppCell | droplet-Bladder-nan-3m-Hematologic|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.07e-07 | 163 | 194 | 8 | 6c2967dee563295febe2adabf503d095cb911ccf | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-07 | 173 | 194 | 8 | a0e4d25db186b9f7ff819abc0db68ad58c92ba3b | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.52e-07 | 173 | 194 | 8 | 1ea8b8b89611bebf6acb700fb04a7d38720775a9 | |
| ToppCell | 5'-Adult-Appendix-Hematopoietic-Myeloid-LYVE1+_Macrophage|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.28e-06 | 180 | 194 | 8 | 66c7b02d85e32ba3e7530d0c4aff17e7525ccdd8 | |
| ToppCell | Control-Myeloid-Dendritic_cells|Control / group, cell type (main and fine annotations) | 1.28e-06 | 180 | 194 | 8 | 25ad95c3c30e3b82abe93bd77ba003f5c2241f7c | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.51e-06 | 184 | 194 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.71e-06 | 187 | 194 | 8 | c41a2c81dd2ceef303f39f699032aa7d6ea67cf0 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.78e-06 | 188 | 194 | 8 | 3be2d50148daa4eddddc2c7f269f45c97f7e4931 | |
| ToppCell | PCW_07-8.5-Hematologic_Myeloid-Hem_Myeloid_dendritic-im_migrating_dendritic_(5)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.78e-06 | 188 | 194 | 8 | 8fc15c8b78fdd1a578e34325011bc5a87a8aab31 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.00e-06 | 191 | 194 | 8 | 24d75b7e1d6fb9d24aa7844f584ee888a449841f | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.00e-06 | 191 | 194 | 8 | 468b5149d1533f03521844d3cce8633d44eb6ed4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Neuronal-neurons_A|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.16e-06 | 193 | 194 | 8 | a189d46c39067b717509cd144e0225cc93d7731d | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 193 | 194 | 8 | bd08555f02db8bc903caacae57e80bb91e2556ce | |
| ToppCell | Adult-Immune-interstitial_macrophage_(C1Q_positive)|Adult / Lineage, Cell type, age group and donor | 2.16e-06 | 193 | 194 | 8 | 31c0978ba78c9516d498aec0798902e57555e557 | |
| ToppCell | RA-08._Macrophage|World / Chamber and Cluster_Paper | 2.16e-06 | 193 | 194 | 8 | 5fd22db1825d105709fcc0aa4955c99a117e3c82 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.16e-06 | 193 | 194 | 8 | 374d0526a071e973c3f43b4564f78f6933bb67ed | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.24e-06 | 194 | 194 | 8 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | Children_(3_yrs)-Immune-alveolar_macrophage_(MARCO_positive)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.33e-06 | 195 | 194 | 8 | 9d649ac7d2af313481069c95349efc0c68449e2b | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-06 | 195 | 194 | 8 | 09df40ff9b493170861b3f6e57a942a834655b5c | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.33e-06 | 195 | 194 | 8 | c14d730dd5c94247bc09711eaa5a53bd5a5957be | |
| ToppCell | (3)_MNP-(3)_Macrophage_MARCOneg|(3)_MNP / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.33e-06 | 195 | 194 | 8 | e4b5e4b8832669fb4d1661ecd828b81e621d35c4 | |
| ToppCell | Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.33e-06 | 195 | 194 | 8 | 312d9625655b38f1a7c2bf8f8bb7b667ebdf9617 | |
| ToppCell | proximal-3-Hematologic-Nonclassical_Monocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 196 | 194 | 8 | e426d02c6bcff2358a45e627cc86389070a4af25 | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 196 | 194 | 8 | 7e136975e5943d42d51d8cc91c912547ef79cf4d | |
| ToppCell | proximal-Hematologic-Nonclassical_Monocyte|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.42e-06 | 196 | 194 | 8 | 439d695526714772971fd1a4a92b8b6a84eee1a4 | |
| ToppCell | COVID-19-lung-Macrophage_metabolically_active|lung / Disease (COVID-19 only), tissue and cell type | 2.42e-06 | 196 | 194 | 8 | a753d76d764c181eecb0e17a794a2e7d0ff70136 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 197 | 194 | 8 | 759f26753f76af3ae8d8527c4d221206245a3d45 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 194 | 8 | c9b1f2ee7eb31a66af331c5aae29e1bbb5186f5a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 194 | 8 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 197 | 194 | 8 | 10190b877bf46ba2163d203df9dd3b498c66e52f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Macrophage_Dendritic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 194 | 8 | d95565652ca318a2298d6918d54ba6367e9560f4 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-LYVE1+_Macrophage|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.51e-06 | 197 | 194 | 8 | 1c0024049db2d2c817a7f503de235b9630b24e33 | |
| ToppCell | kidney_cells-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.51e-06 | 197 | 194 | 8 | 49511ea2330a516456007e73bc3195334433011c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_naive-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.51e-06 | 197 | 194 | 8 | 4a6eff66a17c5e89bda61d887b736f5c62b93bd7 | |
| ToppCell | Adult-Immune|Adult / Lineage, Cell type, age group and donor | 2.61e-06 | 198 | 194 | 8 | 9bfd7b88aa646eaf5eddb15cf985c7ca910cb35e | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Hematopoietic-Myeloid|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 198 | 194 | 8 | be038619157aeaa7a57ebd66392de940df4f8127 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 198 | 194 | 8 | 96883ad8e189a46ed5b7eaafc0543e53682d26ed | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Hematopoietic-Myeloid-Macrophages|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.61e-06 | 198 | 194 | 8 | 88635244a0b306d2cc50b8412fe47bb359c9cf00 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.61e-06 | 198 | 194 | 8 | 0b41b3d6c2db795320e8b65d40d85fb8b618cc34 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.71e-06 | 199 | 194 | 8 | 04adf46975aa4194ea40c7480f8a517def5d929c | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.71e-06 | 199 | 194 | 8 | b827dd8a249f904a0ff930a6c4d3b00fb7bc6fb1 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-06 | 199 | 194 | 8 | b44d06c650298b20c26747466e17382c88df1907 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.71e-06 | 199 | 194 | 8 | 1413156b7be5373fd02bbe39ec50ccfe165fa6d1 | |
| ToppCell | wk_20-22-Hematologic-Myeloid-SPP1+_Mac|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 2.71e-06 | 199 | 194 | 8 | 7c19f1b1f4369edd035ca9cdcf4e653771fc4648 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Hematopoietic-Myeloid|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.71e-06 | 199 | 194 | 8 | f34c15df58fbdc6c90e30800e26fabbf828ad10b | |
| ToppCell | Fetal_29-31_weeks-Immune-alveolar_macrophage_(MARCO_positive)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.71e-06 | 199 | 194 | 8 | 22001aa733273e784051b7f750e07d99aaf7a225 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-06 | 199 | 194 | 8 | f965eb89d6d023c83154276b8fded490fd89c100 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_macrophage-macrophage|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.71e-06 | 199 | 194 | 8 | c0dcdda30485bb920d3706dcfb06f11b76b6ea37 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.71e-06 | 199 | 194 | 8 | 379bbd9cecf466b902411c54d74bd9885285b1ba | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-06 | 200 | 194 | 8 | f3dc07a7cc8cf041da8fe610d21af595818cf2d8 | |
| ToppCell | Parenchymal-10x5prime-Immune_Myeloid-Monocytic-Monocyte_CD16|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-06 | 200 | 194 | 8 | 83d9aa5b46ae7a71a258b2e44b3251f95bc9a1b7 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-mo-Mac|Myeloid_cells / Location, Cell class and cell subclass | 2.81e-06 | 200 | 194 | 8 | 195862a319794e57f0506757ae45ab70200bc5b4 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.81e-06 | 200 | 194 | 8 | 390f9429feae991b8524e2815d8fcd4914c74459 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.81e-06 | 200 | 194 | 8 | 5432bdf495431cd26f6e4cd585100f3652588913 | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-06 | 200 | 194 | 8 | f7e9b4a8ededb116774528b38ea3381b6f05915c | |
| ToppCell | Lung_Parenchyma-Control-Myeloid-MoAM|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.81e-06 | 200 | 194 | 8 | d98c523ac0e4767aaeef50cae142513d115212ab | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-MoAM-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.81e-06 | 200 | 194 | 8 | 59b2ebb69699c9bebf8c2697eb678fdccd0a998c | |
| ToppCell | Children_(3_yrs)-Immune-monocyte-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.81e-06 | 200 | 194 | 8 | 881ab995c90d75fd987d6e8f1f926a4bfcc4235f | |
| Drug | AC1L1CR9 | 1.84e-08 | 21 | 196 | 6 | CID000002023 | |
| Drug | Br2BAPTA | 1.83e-07 | 7 | 196 | 4 | CID003081001 | |
| Drug | isradipine | 2.47e-06 | 100 | 196 | 8 | CID000003784 | |
| Drug | GTP[S] | MAN2A1 COPB2 RYR1 RYR3 ITPR1 MALT1 SNAP91 SCN10A CACNA1I PLCB4 RAB3A RAPGEF4 ARFGEF1 RAB3D RGS12 PRKCB GPSM1 MX1 | 3.89e-06 | 591 | 196 | 18 | CID000001764 |
| Drug | 3,4-dihydroxybenzoate | 6.20e-06 | 5 | 196 | 3 | ctd:C520290 | |
| Drug | ferric ammonium citrate | 8.76e-06 | 33 | 196 | 5 | CID000014457 | |
| Drug | CNS 1145 | 8.76e-06 | 33 | 196 | 5 | CID000190902 | |
| Drug | IHC-64 | 8.76e-06 | 33 | 196 | 5 | CID000162753 | |
| Drug | 2alpha-propoxy-1alpha,25-dihydroxyvitamin D3 | 1.23e-05 | 6 | 196 | 3 | CID010062706 | |
| Drug | mag-fura-2 | 1.57e-05 | 37 | 196 | 5 | CID000123839 | |
| Drug | fura 2 | 2.04e-05 | 65 | 196 | 6 | CID000057054 | |
| Drug | fenvalerate | 2.10e-05 | 97 | 196 | 7 | ctd:C017690 | |
| Drug | [[(2R,3S,4R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] [(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methyl hydrogen phosphate | 2.14e-05 | 7 | 196 | 3 | CID009547999 | |
| Disease | Colorectal Carcinoma | LRRC4 KMT2C NF1 PKHD1 PAN2 IQUB RASAL2 SLC11A2 ARFGEF1 ABCC5 IDH1 SLC44A4 MLH3 DUSP21 PRKCB EIF3H | 1.39e-05 | 702 | 190 | 16 | C0009402 |
| Disease | Anaplastic astrocytoma | 2.60e-05 | 27 | 190 | 4 | C0334579 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 4.10e-05 | 195 | 190 | 8 | DOID:1574 (implicated_via_orthology) | |
| Disease | chromosome 1p36 deletion syndrome (implicated_via_orthology) | 4.12e-05 | 2 | 190 | 2 | DOID:0060410 (implicated_via_orthology) | |
| Disease | congenital myopathy 1A (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:3529 (implicated_via_orthology) | |
| Disease | malignant hyperthermia (implicated_via_orthology) | 1.23e-04 | 3 | 190 | 2 | DOID:8545 (implicated_via_orthology) | |
| Disease | Food Allergy | 1.23e-04 | 3 | 190 | 2 | C0016470 | |
| Disease | cryptorchidism (is_implicated_in) | 2.45e-04 | 4 | 190 | 2 | DOID:11383 (is_implicated_in) | |
| Disease | cancer (implicated_via_orthology) | 3.65e-04 | 268 | 190 | 8 | DOID:162 (implicated_via_orthology) | |
| Disease | juvenile myelomonocytic leukemia (implicated_via_orthology) | 4.07e-04 | 5 | 190 | 2 | DOID:0050458 (implicated_via_orthology) | |
| Disease | polybrominated biphenyl measurement, gestational serum measurement, polybrominated diphenyl ether measurement | 4.07e-04 | 5 | 190 | 2 | EFO_0007961, EFO_0007962, EFO_0007964 | |
| Disease | Intrahepatic Cholangiocarcinoma | 4.81e-04 | 24 | 190 | 3 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 4.81e-04 | 24 | 190 | 3 | C3805278 | |
| Disease | Cerebral Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0750935 | |
| Disease | Intracranial Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0750936 | |
| Disease | Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0004114 | |
| Disease | Grade I Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 5.44e-04 | 25 | 190 | 3 | C0547065 | |
| Disease | Pilocytic Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0280783 | |
| Disease | Diffuse Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 5.44e-04 | 25 | 190 | 3 | C0338070 | |
| Disease | Cholangiocarcinoma | 6.13e-04 | 26 | 190 | 3 | C0206698 | |
| Disease | Gemistocytic astrocytoma | 6.13e-04 | 26 | 190 | 3 | C0334581 | |
| Disease | Protoplasmic astrocytoma | 6.13e-04 | 26 | 190 | 3 | C0334580 | |
| Disease | Fibrillary Astrocytoma | 6.13e-04 | 26 | 190 | 3 | C0334582 | |
| Disease | Insulin Resistance | 6.13e-04 | 60 | 190 | 4 | C0021655 | |
| Disease | Insulin Sensitivity | 6.13e-04 | 60 | 190 | 4 | C0920563 | |
| Disease | epilepsy (implicated_via_orthology) | 6.78e-04 | 163 | 190 | 6 | DOID:1826 (implicated_via_orthology) | |
| Disease | Prostatic Neoplasms | TPT1 HIF1A CASZ1 ITPR1 KMT2C USP7 IDH1 XPO1 AR USO1 ITSN2 EIF3H | 6.90e-04 | 616 | 190 | 12 | C0033578 |
| Disease | Malignant neoplasm of prostate | TPT1 HIF1A CASZ1 ITPR1 KMT2C USP7 IDH1 XPO1 AR USO1 ITSN2 EIF3H | 6.90e-04 | 616 | 190 | 12 | C0376358 |
| Disease | aflatoxins-related hepatocellular carcinoma (biomarker_via_orthology) | 8.48e-04 | 7 | 190 | 2 | DOID:5022 (biomarker_via_orthology) | |
| Disease | prostate cancer (is_implicated_in) | 9.83e-04 | 117 | 190 | 5 | DOID:10283 (is_implicated_in) | |
| Disease | alcohol dependence (biomarker_via_orthology) | 1.13e-03 | 8 | 190 | 2 | DOID:0050741 (biomarker_via_orthology) | |
| Disease | autoimmune disease (is_implicated_in) | 1.13e-03 | 8 | 190 | 2 | DOID:417 (is_implicated_in) | |
| Disease | Acute Myeloid Leukemia, M1 | 1.32e-03 | 125 | 190 | 5 | C0026998 | |
| Disease | Acute Myeloid Leukemia (AML-M2) | 1.32e-03 | 125 | 190 | 5 | C1879321 | |
| Disease | pneumonia (implicated_via_orthology) | 1.79e-03 | 10 | 190 | 2 | DOID:552 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (biomarker_via_orthology) | 1.80e-03 | 80 | 190 | 4 | DOID:6432 (biomarker_via_orthology) | |
| Disease | Neoplasm Recurrence, Local | 2.03e-03 | 39 | 190 | 3 | C0027643 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.11e-03 | 139 | 190 | 5 | DOID:3908 (is_implicated_in) | |
| Disease | Neoplastic Cell Transformation | 2.11e-03 | 139 | 190 | 5 | C0007621 | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.15e-03 | 84 | 190 | 4 | DOID:9119 (is_implicated_in) | |
| Disease | Bladder Neoplasm | 2.17e-03 | 140 | 190 | 5 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 2.24e-03 | 141 | 190 | 5 | C0005684 | |
| Disease | Intellectual Disability | 2.56e-03 | 447 | 190 | 9 | C3714756 | |
| Disease | rheumatoid arthritis (implicated_via_orthology) | 2.61e-03 | 12 | 190 | 2 | DOID:7148 (implicated_via_orthology) | |
| Disease | bronchopulmonary dysplasia (biomarker_via_orthology) | 2.61e-03 | 12 | 190 | 2 | DOID:11650 (biomarker_via_orthology) | |
| Disease | level of Phosphatidylinositol (16:0_18:1) in blood serum | 2.61e-03 | 12 | 190 | 2 | OBA_2045152 | |
| Disease | Hereditary hemochromatosis | 2.61e-03 | 12 | 190 | 2 | C0392514 | |
| Disease | Hemochromatosis | 2.61e-03 | 12 | 190 | 2 | C0018995 | |
| Disease | lymphocyte count | PHF19 UBE4B OR2W5P HORMAD1 CASZ1 ITPR1 EPS15L1 USP7 PHLPP1 C3 MMS22L FLT3 DOCK10 ABCC5 BEND3 GIMAP8 DNAH17 PRKCB ACAP2 | 2.98e-03 | 1464 | 190 | 19 | EFO_0004587 |
| Disease | 1-stearoyl-2-linoleoyl-GPI (18:0/18:2) measurement | 3.07e-03 | 13 | 190 | 2 | EFO_0800413 | |
| Disease | wet macular degeneration | 3.57e-03 | 14 | 190 | 2 | EFO_0004683 | |
| Disease | Kidney Failure, Chronic | 3.67e-03 | 48 | 190 | 3 | C0022661 | |
| Disease | myocardial infarction (biomarker_via_orthology) | 3.86e-03 | 160 | 190 | 5 | DOID:5844 (biomarker_via_orthology) | |
| Disease | hepatocellular carcinoma (implicated_via_orthology) | 3.89e-03 | 49 | 190 | 3 | DOID:684 (implicated_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 3.90e-03 | 99 | 190 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | neuroimaging measurement | WARS2 NF1 SNAP91 MTMR2 PKHD1 MRC1 SZT2 C5orf63 DOCK9 BEND3 RPSA XPO1 SLC40A1 CRMP1 DNAJA3 | 4.03e-03 | 1069 | 190 | 15 | EFO_0004346 |
| Disease | P wave duration | 4.10e-03 | 15 | 190 | 2 | EFO_0005094 | |
| Disease | brain ischemia (biomarker_via_orthology) | 4.33e-03 | 102 | 190 | 4 | DOID:2316 (biomarker_via_orthology) | |
| Disease | gliosarcoma | 4.66e-03 | 16 | 190 | 2 | C0206726 | |
| Disease | Dystonia, Limb | 5.26e-03 | 17 | 190 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 5.26e-03 | 17 | 190 | 2 | C0393610 | |
| Disease | non-Hodgkin lymphoma (is_implicated_in) | 5.26e-03 | 17 | 190 | 2 | DOID:0060060 (is_implicated_in) | |
| Disease | Leukemia, Myelocytic, Acute | 5.36e-03 | 173 | 190 | 5 | C0023467 | |
| Disease | Cholestasis | 5.66e-03 | 110 | 190 | 4 | C0008370 | |
| Disease | Glioblastoma Multiforme | 5.84e-03 | 111 | 190 | 4 | C1621958 | |
| Disease | Dystonia, Paroxysmal | 5.90e-03 | 18 | 190 | 2 | C0393588 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| AFTKNRMNYTNKFLL | 126 | O95150 | |
| NLTLNQVLSFDYDMG | 91 | A6NC05 | |
| NFLQQLYKFMEDRGT | 311 | Q4LE39 | |
| DQFALAMYFIQQKVS | 331 | Q9UBC2 | |
| QMDNLYLKALEGFIA | 86 | Q99814 | |
| RNLGYMKINNIQVFG | 656 | Q76B58 | |
| NAMLREGYKTFFNTL | 131 | Q969T7 | |
| QDQEFLKMLNLFYQT | 191 | P20813 | |
| QNLGKLFMAQALQEY | 336 | O15372 | |
| VTNVNDLFFKYSMEG | 216 | Q4G0S4 | |
| ASFNGMYADLLQLVK | 206 | Q8TDL5 | |
| KNIALYLGKQVFFTM | 61 | Q86XM0 | |
| TMNQFVNKFNVLYDR | 301 | Q7L5N1 | |
| VFQYMFATLNSLQGL | 786 | Q6QNK2 | |
| QMQNLVARASKYDFF | 301 | Q86V15 | |
| RDGKNNVAFMSYFLQ | 721 | P35606 | |
| NVAFMSYFLQGKVDA | 726 | P35606 | |
| FRTNEMFINAIKQYL | 471 | Q9Y6D6 | |
| MYLFYGNKTSVQFQN | 776 | O95782 | |
| KAGDFLEANYMNLQR | 1171 | P01024 | |
| ATFMVFQALAQYQKD | 1271 | P01024 | |
| GSAQLLMAQKFYQFR | 836 | O14490 | |
| YNDGVINLLEKFFEM | 211 | O60641 | |
| LLNDYANGFMVSQVL | 11 | P46597 | |
| NKQFMNGIRDLAQYS | 56 | Q15057 | |
| LQAIKEAQVYMGDFN | 1161 | Q96MT7 | |
| SFALKMFLFQFVNLN | 636 | Q9BYT9 | |
| VAQLAFQMAFLRQYG | 466 | P23786 | |
| LSAAIAAMQKFYGLQ | 61 | P50281 | |
| DFNGQKLKLYFAQVQ | 111 | Q9UKA8 | |
| NTSLPQEYFLFQKMQ | 131 | P57052 | |
| PYITNFFNQVLMLGK | 231 | Q9NTI5 | |
| DQNFDYMFKILIIGN | 16 | P20336 | |
| DQNFDYMFKLLIIGN | 16 | P20337 | |
| NFDYMFKLLIIGNSS | 26 | Q96E17 | |
| DQNFDYMFKLLLIGN | 16 | O95716 | |
| KEEFQQYAAALQAGM | 276 | Q08257 | |
| VYAFMNENFKKNVLS | 331 | Q96P65 | |
| RYVMTFLNVLNFGDQ | 261 | Q96AA3 | |
| NDFLLLTYMVKQFAV | 1456 | Q9NZM3 | |
| DYADFQYLKQVLGQM | 101 | P28070 | |
| TDNDPNIYFLIQKMF | 186 | Q5T5X7 | |
| GQLNKDMTYAQLYSF | 436 | P28039 | |
| GFMQDLQQKVVYLSY | 226 | P34810 | |
| MAGNEYVFSQLLQCK | 376 | Q9P2R3 | |
| MLGNFLYKQNVISFD | 81 | P0C7N1 | |
| QAFYNGSLMAQIVKD | 226 | A6NGU5 | |
| ENGILFLTKNNLKYM | 126 | Q504Q3 | |
| AQLLYKTNMNTGFLD | 1391 | Q8NEZ4 | |
| DLQFKNYQQLFDYMN | 436 | Q16706 | |
| QLGFAAEFSNVMIIY | 601 | Q9UDY8 | |
| QEYIAKQFGFMQKQI | 571 | Q14643 | |
| KQFGFMQKQIGYDVL | 576 | Q14643 | |
| GDDFFNMLIKYQSSR | 596 | Q86YR5 | |
| QFIKAYKTGNMDQAL | 56 | Q6ZP29 | |
| AFLLMYAQKNLDIGV | 576 | Q6ZRQ5 | |
| YISDNVNKYMGLTQF | 111 | Q16665 | |
| LKNGSLIFDFEYMVQ | 66 | Q8WX39 | |
| YSVDFMVDNAQLGFL | 1256 | Q10570 | |
| FFQNMLNLYNFSAKV | 571 | P0DPD6 | |
| LNLYNFSAKVMADQL | 576 | P0DPD6 | |
| NFEMYRFLFNIQKQE | 126 | A8MZ26 | |
| LSQPDLVYKFMNLAN | 1076 | Q5VYK3 | |
| NILDSYEMFNLQSKA | 396 | Q9UHC1 | |
| MGKDNASYLQAFILV | 1 | A6NFC9 | |
| FKGNYDFVQAMIVNN | 256 | Q6PIU2 | |
| VQFNSALDMYKLAGA | 106 | Q8IZ57 | |
| LLMDKSIFQGFLNLY | 216 | Q9H4Y5 | |
| FMLVVGLYAANQDQF | 366 | Q96LU7 | |
| ALIKYSMDDQLNQLF | 531 | P63132 | |
| NLANFAKFGNKEEYM | 516 | Q9UJF2 | |
| GFLATVQYQMQFSKA | 491 | Q8N4P6 | |
| AFEGLFNLKYLNLGM | 191 | Q9HBW1 | |
| FENLMKYAFPVSNNL | 176 | Q13614 | |
| FVMAVFGQAFYQKTN | 301 | P49279 | |
| TYSGQFVMEGFLNLK | 391 | P49281 | |
| QDLEMYGVNYFSIKN | 196 | P26038 | |
| EKFDFVLQYLNKMAG | 286 | Q9UI32 | |
| AFQNMNGSEYFVKIQ | 491 | Q13421 | |
| KLFIMNLDQNEFAGF | 646 | P05771 | |
| GLKNQKFFDELRMNY | 821 | P10275 | |
| AKQFMRQAAYQAGLA | 211 | O43301 | |
| VNTKVFQLYRSGLFM | 281 | Q6IE36 | |
| MLGNFLYKQNSISFN | 81 | P0C7N5 | |
| ALIKYSMDDQLNQLF | 531 | P63135 | |
| ALIKYSMDDQLNQLF | 531 | Q9BXR3 | |
| QLMTLAYDNGINLFD | 71 | Q13303 | |
| QYLFKFRATNIMGQF | 1911 | Q9UMZ3 | |
| DYFNQVTLQLLDGFM | 31 | Q8IV76 | |
| ENYNEAKFITFGMLI | 776 | Q5T6X5 | |
| ALIKYSMDDQLNQLF | 531 | Q9QC07 | |
| MNLNGDYATIFNNLL | 771 | O15440 | |
| VFLNNKYDRAMVAFL | 341 | A8MW95 | |
| ANFYKLIQNGFKMDQ | 896 | P36888 | |
| LIQNGFKMDQPFYAT | 901 | P36888 | |
| KQLLEVVLAFGNYMN | 811 | Q9Y4D1 | |
| YTFNLRDLSKVFQGM | 2436 | Q9P2D7 | |
| YELMKNNNFQGFSLS | 191 | Q9NR20 | |
| YLNTFEFMDKLGENL | 391 | O75874 | |
| FSDLQALQVLKMSYN | 101 | Q6WRI0 | |
| NLTANEKYEMFLNQA | 1501 | Q4G0P3 | |
| KRVFDTYMLFFQVNQ | 1516 | Q96BY6 | |
| LYLLMRQNFEIGNNF | 1576 | Q96N67 | |
| FMDRGFVFKQINNYI | 1036 | Q9BZ29 | |
| KYNFDNLGQALMSLF | 1466 | O43497 | |
| FKMLEAYNLTEKNFA | 2521 | Q99715 | |
| DNLQEFMKNFLIYGC | 996 | Q9UFH2 | |
| EYKRNLFGKFQTNMA | 81 | F2Z3M2 | |
| MADLLSYFQQQLTFQ | 156 | Q9UK97 | |
| KLIMTFQNYGQALFK | 271 | Q8IXL6 | |
| FLNQKTVIGYSFMAL | 11 | Q8N5C1 | |
| QIFRSQQDYKMGYFL | 811 | Q8ND61 | |
| YNFDNLGQALMSLFV | 1361 | Q9P0X4 | |
| ARKMAQADQFYSQIL | 796 | Q8NCU4 | |
| FLKMGKNNQSALLYG | 151 | Q9Y375 | |
| TIQNNFGEKFFEYMI | 346 | Q8ND71 | |
| LLEYGNQFQDALYKM | 101 | Q9NS18 | |
| KNGYTAFDLVMLLND | 391 | Q68DC2 | |
| VVLYLNQMGVFNFVD | 76 | Q9Y586 | |
| YMANQEAAIQAFLDK | 456 | Q8NA54 | |
| FPKLIGELFNNMSYN | 71 | Q8IXH8 | |
| QLSIQMANAKFNYGF | 1856 | Q14204 | |
| NRNAYIMIAIYGKNF | 556 | Q53GD3 | |
| QFKFKYTNNGPLMDF | 116 | Q86X24 | |
| AQLLGLVYMKFVASN | 281 | Q08722 | |
| LTNSQNFDEYMKALG | 11 | O15540 | |
| YFMELTFNQAAKGVN | 211 | Q96EY1 | |
| EKAQELLKFLQMNGY | 2921 | P21817 | |
| VQDKGVNSFQVYMAY | 156 | Q14194 | |
| YEFKLFNNNTVRMIN | 156 | Q9H596 | |
| QAFYNGSLMAQIVKD | 226 | P36268 | |
| MTGKNVYFQSQLEAF | 1 | Q9H8Q6 | |
| QQQSLFGIFLCMYLV | 21 | Q8NGS0 | |
| FFNYGNRQEKNIMLY | 116 | P22897 | |
| QNLGLSEMYFNYETK | 1001 | Q96P20 | |
| VINGEMQFYARAKLF | 61 | Q5VVY1 | |
| MLGNFLYKQNVISFD | 81 | Q8NH10 | |
| NYLGKKTNQMLEAFE | 221 | Q9BXD5 | |
| FVSQKNMEDYLQALN | 11 | P82980 | |
| GGTNLDFQMEQYIYK | 26 | P08865 | |
| YQDAFLFNELKGETM | 446 | Q9Y230 | |
| LTGYFPQDKSNFQQM | 141 | Q86VV8 | |
| MELVQDLAQGFNKKY | 186 | Q9UGM6 | |
| LNAFSVVNRKNMFVY | 2071 | Q5T011 | |
| NQNFFKEGSYIQRMK | 246 | O60763 | |
| EYKNLNSFFAIVMGL | 856 | Q8WZA2 | |
| FKQLLMVGGLDRYFQ | 246 | Q6PI48 | |
| LSNKCGFQLQYQMIF | 231 | Q9UI12 | |
| VINQMLVFFAAKNFL | 281 | Q6ZUK4 | |
| LAMQLNQGKFEYNGS | 656 | Q15147 | |
| QMFSSEAYGQKDLLF | 311 | P08582 | |
| VVLYLNQMGVFNFVD | 76 | Q13394 | |
| DQLGNIMSGYEFINK | 246 | Q9Y2Z4 | |
| MLNNKVGNFKFIYVD | 206 | Q9NSI8 | |
| EQYSKRFNEFMSNIL | 401 | P78356 | |
| LNKCLMNFKLGNFSY | 316 | Q96PZ0 | |
| MNFKLGNFSYQKNPL | 321 | Q96PZ0 | |
| QAMNSLKEIGFINYY | 361 | Q96PZ0 | |
| TYNGFLEIMKEFKSQ | 61 | O75182 | |
| FRFASYINNDMVLQK | 26 | Q9HAT2 | |
| GLNSLFFLSMVNNYL | 231 | Q8WXD0 | |
| NLFTKNLTPMNYNIF | 306 | Q9H5Q4 | |
| IMYFRFAQNTLGNKL | 536 | Q9NP59 | |
| MLYALLNKTFAQDGQ | 256 | Q96QE5 | |
| LLNESIGANYFNIMD | 3526 | P08F94 | |
| IEFNKALLAMYTNQA | 306 | O76094 | |
| KYQLQSQENFEAFMK | 6 | P07148 | |
| FSGIYLMFYNQTKNI | 191 | Q96DW6 | |
| LYMQIINFFKGLSCA | 286 | Q7Z7C7 | |
| VFKASRSNNFYLGML | 626 | Q8TDI8 | |
| LQSFDAALYLQMNEK | 346 | Q9Y6X2 | |
| MKQFLLYLDESNALG | 16 | Q6ZYL4 | |
| ILEFSQNMNTKYYGL | 66 | O14980 | |
| GYSQQDAQEFLKLLM | 296 | Q9UK80 | |
| VSYQKAMFIFLSNAG | 196 | O14656 | |
| MVNLLIAFFNNVYLD | 1061 | Q9BX84 | |
| QQLQIFNLMKFDSYT | 806 | O14924 | |
| VNKFQMAYSNLLRAN | 76 | P37108 | |
| VQNMALYADVGGKQF | 61 | P51571 | |
| INGLGDIMNNKVFYQ | 2041 | Q15413 | |
| VKVNFDNVAMGYLAL | 1346 | Q9Y5Y9 | |
| EFNSGKQFVRYINML | 1016 | O95155 | |
| LANFKNYQFFIGENM | 126 | P13693 | |
| ALIKYSMDDQLNQLF | 531 | P10266 | |
| YNFLQKNDLNPMFLD | 431 | Q9Y263 | |
| ALIKYSMDDQLNQLF | 531 | P63133 | |
| NNMRIFGEAAEKNLY | 66 | P21359 | |
| ALIKYSMDDQLNQLF | 531 | Q9UQG0 | |
| NNFKDLMSKLTEGQY | 31 | Q5T6S3 | |
| RLNEFMAGFYIITNK | 1131 | Q9NTJ3 | |
| MYLNFAEIGSNIKNL | 276 | Q9NRW7 | |
| KQAIGMLFIHFANVY | 76 | Q86TL2 | |
| VFNNFQDQMKRELAY | 971 | Q2VWA4 | |
| LENMKQLSYLGLSFN | 756 | O60346 | |
| YLQNTGKMKNFADLE | 231 | Q9BXT5 | |
| FKASRSNNFYMGLLL | 686 | Q8TDI7 | |
| DVMLENFQNLASLGY | 46 | Q32M78 | |
| GMRKYFLQANDQQDL | 86 | Q9HB21 | |
| VRYNFMNDGFFLKVT | 126 | Q96LC7 | |
| QQFQGKESAYMLFYR | 466 | Q9NVE5 | |
| LAQSQKGLLFFMSEY | 711 | Q69YN4 | |
| NTDPMLLQFFKSQGY | 831 | Q93009 | |
| FYALKGMFLAQINKS | 3121 | Q9Y4A5 | |
| IQNFSYETFQQKMLR | 251 | Q15554 | |
| NLYNNIRLFEKGMKF | 546 | O94874 | |
| GMVTFNLYHFLEVNK | 501 | Q9NX78 | |
| QFFMLQTYGQQLQKA | 601 | P20591 | |
| MGSLVKDYFARQQNL | 201 | Q9UHQ1 | |
| MLRLGNADNFNYTKQ | 276 | Q9Y4I1 | |
| VFKQLFYMINAVTLN | 1681 | Q9ULV0 | |
| DQFLLMYTAGFLQIQ | 96 | Q96RE7 |